Cargando…

Identification of mutations that causes glucose-6-phosphate transporter defect in tunisian patients with glycogenosis type 1b

BACKGROUND: Glycogen storage disease type 1b (GSD1b) is an autosomal recessive lysosomal storage disease caused by defective glucose-6-phosphate transporter encoded by SLC37A4 leading to the accumulation of glycogen in various tissues. The high rate of consanguineous marriages in Tunisian population...

Descripción completa

Detalles Bibliográficos
Autores principales: Chkioua, Latifa, Amri, Yessine, Sahli, Chayma, Rhouma, Ferdawes Ben, Chehida, Amel Ben, Tebib, Neji, Messaoud, Taieb, Abdennebi, Hassen Ben, Laradi, Sandrine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142411/
https://www.ncbi.nlm.nih.gov/pubmed/37118808
http://dx.doi.org/10.1186/s13098-023-01065-2
_version_ 1785033606841761792
author Chkioua, Latifa
Amri, Yessine
Sahli, Chayma
Rhouma, Ferdawes Ben
Chehida, Amel Ben
Tebib, Neji
Messaoud, Taieb
Abdennebi, Hassen Ben
Laradi, Sandrine
author_facet Chkioua, Latifa
Amri, Yessine
Sahli, Chayma
Rhouma, Ferdawes Ben
Chehida, Amel Ben
Tebib, Neji
Messaoud, Taieb
Abdennebi, Hassen Ben
Laradi, Sandrine
author_sort Chkioua, Latifa
collection PubMed
description BACKGROUND: Glycogen storage disease type 1b (GSD1b) is an autosomal recessive lysosomal storage disease caused by defective glucose-6-phosphate transporter encoded by SLC37A4 leading to the accumulation of glycogen in various tissues. The high rate of consanguineous marriages in Tunisian population provides an ideal environment to facilitate the identification of homozygous pathogenic mutations. We aimed to determine the clinical and genetic profiles of patients with GSD1b to evaluate SLC37A4 mutations spectrum in Tunisian patients. METHODS: All exons and flanking intron regions of SLC37A4 gene were screened by direct sequencing to identify mutations and polymorphisms in three unrelated families with GSD1b. Bioinformatics tools were then used to predict the impacts of identified mutations on the structure and function of protein in order to propose a function-structure relationship of the G6PT1 protein. RESULTS: Three patients (MT, MB and SI) in Families I, II and III who had the severe phenotype were homoallelic for the two identified mutations: p.R300H (famillies I, II) and p.W393X (Family III), respectively. One of the alterations was a missense mutation p.R300H of exon 6 in SLC37A4 gene. The analysis of the protein structure flexibility upon p.R300H mutation using DynaMut tool and CABS-flex 2.0 server showed that the reported mutation increase the molecule flexibility of in the cytosol region and would probably lead to significant conformational changes. CONCLUSION: This is the first Tunisian report of SLC37A4 mutations identified in Tunisia causing the glycogenosis type Ib disease. Bioinformatics analysis allowed us to establish an approximate structure-function relationship for the G6PT1 protein, thereby providing better genotype/phenotype correlation knowledge.
format Online
Article
Text
id pubmed-10142411
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101424112023-04-29 Identification of mutations that causes glucose-6-phosphate transporter defect in tunisian patients with glycogenosis type 1b Chkioua, Latifa Amri, Yessine Sahli, Chayma Rhouma, Ferdawes Ben Chehida, Amel Ben Tebib, Neji Messaoud, Taieb Abdennebi, Hassen Ben Laradi, Sandrine Diabetol Metab Syndr Research BACKGROUND: Glycogen storage disease type 1b (GSD1b) is an autosomal recessive lysosomal storage disease caused by defective glucose-6-phosphate transporter encoded by SLC37A4 leading to the accumulation of glycogen in various tissues. The high rate of consanguineous marriages in Tunisian population provides an ideal environment to facilitate the identification of homozygous pathogenic mutations. We aimed to determine the clinical and genetic profiles of patients with GSD1b to evaluate SLC37A4 mutations spectrum in Tunisian patients. METHODS: All exons and flanking intron regions of SLC37A4 gene were screened by direct sequencing to identify mutations and polymorphisms in three unrelated families with GSD1b. Bioinformatics tools were then used to predict the impacts of identified mutations on the structure and function of protein in order to propose a function-structure relationship of the G6PT1 protein. RESULTS: Three patients (MT, MB and SI) in Families I, II and III who had the severe phenotype were homoallelic for the two identified mutations: p.R300H (famillies I, II) and p.W393X (Family III), respectively. One of the alterations was a missense mutation p.R300H of exon 6 in SLC37A4 gene. The analysis of the protein structure flexibility upon p.R300H mutation using DynaMut tool and CABS-flex 2.0 server showed that the reported mutation increase the molecule flexibility of in the cytosol region and would probably lead to significant conformational changes. CONCLUSION: This is the first Tunisian report of SLC37A4 mutations identified in Tunisia causing the glycogenosis type Ib disease. Bioinformatics analysis allowed us to establish an approximate structure-function relationship for the G6PT1 protein, thereby providing better genotype/phenotype correlation knowledge. BioMed Central 2023-04-28 /pmc/articles/PMC10142411/ /pubmed/37118808 http://dx.doi.org/10.1186/s13098-023-01065-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Chkioua, Latifa
Amri, Yessine
Sahli, Chayma
Rhouma, Ferdawes Ben
Chehida, Amel Ben
Tebib, Neji
Messaoud, Taieb
Abdennebi, Hassen Ben
Laradi, Sandrine
Identification of mutations that causes glucose-6-phosphate transporter defect in tunisian patients with glycogenosis type 1b
title Identification of mutations that causes glucose-6-phosphate transporter defect in tunisian patients with glycogenosis type 1b
title_full Identification of mutations that causes glucose-6-phosphate transporter defect in tunisian patients with glycogenosis type 1b
title_fullStr Identification of mutations that causes glucose-6-phosphate transporter defect in tunisian patients with glycogenosis type 1b
title_full_unstemmed Identification of mutations that causes glucose-6-phosphate transporter defect in tunisian patients with glycogenosis type 1b
title_short Identification of mutations that causes glucose-6-phosphate transporter defect in tunisian patients with glycogenosis type 1b
title_sort identification of mutations that causes glucose-6-phosphate transporter defect in tunisian patients with glycogenosis type 1b
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142411/
https://www.ncbi.nlm.nih.gov/pubmed/37118808
http://dx.doi.org/10.1186/s13098-023-01065-2
work_keys_str_mv AT chkioualatifa identificationofmutationsthatcausesglucose6phosphatetransporterdefectintunisianpatientswithglycogenosistype1b
AT amriyessine identificationofmutationsthatcausesglucose6phosphatetransporterdefectintunisianpatientswithglycogenosistype1b
AT sahlichayma identificationofmutationsthatcausesglucose6phosphatetransporterdefectintunisianpatientswithglycogenosistype1b
AT rhoumaferdawesben identificationofmutationsthatcausesglucose6phosphatetransporterdefectintunisianpatientswithglycogenosistype1b
AT chehidaamelben identificationofmutationsthatcausesglucose6phosphatetransporterdefectintunisianpatientswithglycogenosistype1b
AT tebibneji identificationofmutationsthatcausesglucose6phosphatetransporterdefectintunisianpatientswithglycogenosistype1b
AT messaoudtaieb identificationofmutationsthatcausesglucose6phosphatetransporterdefectintunisianpatientswithglycogenosistype1b
AT abdennebihassenben identificationofmutationsthatcausesglucose6phosphatetransporterdefectintunisianpatientswithglycogenosistype1b
AT laradisandrine identificationofmutationsthatcausesglucose6phosphatetransporterdefectintunisianpatientswithglycogenosistype1b